Wall Street

Business

1-800-FLOWERS Posts Mixed Q4: Revenue Slips but Profitability Soars on Cost-Cutting Drive

The floral and gift e-commerce giant 1-800-FLOWERS reported a 9.5% year-over-year revenue decline to $702.2 million for its fiscal fourth quarter, aligning with Wall Street's subdued expectations. However, disciplined cost management fueled a significant earnings beat, with non-GAAP EPS of $1.20 surging 39.5% above estimates.

Jan 30, 2026

Business

Trane Technologies Posts Strong Q4 on Data Center, Commercial HVAC Boom; Backlog Reaches Record High

Trane Technologies (TT) surpassed Wall Street expectations for Q4 2025, driven by surging demand in commercial HVAC systems and data center infrastructure. The company reported revenue of $5.14B, up 5.5% year-over-year, with earnings per share of $2.86. Management expressed confidence for 2026, citing a record order backlog.

Jan 30, 2026

Business

Cathie Wood's $26 Million Bet on Broadcom: A Signal for AI Chip Dominance?

ARK Invest's Cathie Wood made a significant $26 million investment in Broadcom stock last week, highlighting a strategic pivot towards AI infrastructure amid portfolio reshuffling. The move follows Broadcom's blockbuster earnings and comes as Wall Street maintains a bullish outlook on the chipmaker.

Jan 30, 2026

Business

Long Island Financial Advisor Sentenced to Six Years in Prison for Swindling California Couple Out of Over $1 Million

A former investment advisor with ties to major Wall Street firms has been sentenced to six years behind bars for orchestrating a million-dollar fraud scheme, using client funds to finance a luxury lifestyle that included high-end cars and country club memberships.

Jan 30, 2026

Business

Intel's AI Ambitions Hit Supply Wall; Nvidia's Grip on Chip Market Tightens

Intel's latest earnings reveal persistent supply challenges in the AI chip race, while Nvidia's strategic control over production capacity cements its long-term dominance, analysts say.

Jan 30, 2026

Business

Alumis Soars as Psoriasis Drug Hits All Phase 3 Goals, Drawing Bullish Analyst Praise

Clinical-stage biopharma Alumis Inc. (ALMS) is gaining significant Wall Street attention after its lead drug candidate, envudeucitinib, successfully met all endpoints in key Phase 3 trials for plaque psoriasis, prompting multiple analyst upgrades and optimistic price targets.

Jan 30, 2026

Business

Church & Dwight Meets Q4 Forecasts Amid Sluggish Growth, Stock Rises on Margin Beat

Consumer staples giant Church & Dwight (NYSE:CHD) reported fourth-quarter revenue in line with Wall Street expectations, though underlying organic sales showed signs of stagnation. The company's gross margin outperformance provided a bright spot, lifting shares post-earnings.

Jan 30, 2026

Business

Analysts Boost Outlook for Karman Holdings, Forecasting 66% Revenue Surge by 2026

Wall Street firms have issued a series of bullish upgrades for Karman Holdings Inc. (KRMN), significantly raising revenue projections and price targets for the specialty materials company as growth expectations accelerate.

Jan 30, 2026

Business

Analysts Bullish on Americas Gold and Silver: Revenue Forecasts Skyrocket by 265%

Wall Street analysts have issued a dramatic upgrade to revenue projections for Americas Gold and Silver Corp., forecasting a surge to $383 million by 2026 and signaling accelerated growth far beyond industry peers.

Jan 30, 2026

US

Community Mourns Skid Row Advocate Shirley Raines; Family Awaits Official Cause of Death

As authorities continue their investigation, the family of Shirley Raines—founder of the nonprofit Beauty 2 The Streetz—shares insights into the activist's sudden passing, while tributes pour in from the community she served and celebrities she inspired.

Feb 2, 2026

Business

STKS Price Target Cut After Q4 Revenue Shortfall, But Analysts See Long-Term Upside

Lake Street Capital maintains a Buy rating on The ONE Group Hospitality (STKS) despite lowering its price target, citing a solid finish in a tough market and a clear growth runway through 2026.

Feb 2, 2026

Business

CrossCurve Vows Legal Pursuit Following $3 Million Cross-Chain Bridge Breach

The decentralized finance protocol has publicly identified wallets linked to a weekend exploit, warning of criminal and civil action if funds are not returned within 72 hours, as security firms point to a critical validation flaw.

Feb 2, 2026

Business

Three Financial Stocks on Shaky Ground as Sector Lags Broader Market

The financial services sector, a traditional engine of economic growth, is underperforming the S&P 500 amid economic uncertainty. We examine three specific stocks—Invesco, Enova International, and Sixth Street Specialty Lending—that investors may want to approach with heightened caution.

Jan 30, 2026

Business

Eagle Materials Navigates Mixed Construction Landscape with Strong Heavy Materials Performance in Q3

Eagle Materials (NYSE: EXP) posted resilient fiscal Q3 2026 results, with revenue reaching $556 million and EPS at $3.22. While wallboard sales softened, robust growth in cement and aggregates, fueled by infrastructure spending, highlights a strategic pivot. The company also outlined operational efficiency drives and a fortified balance sheet.

Jan 30, 2026

Business

Asia Markets Rebound Sharply on Tech Rally, Eyes on Earnings and Trade Tensions

Asian equities staged a strong recovery on Tuesday, with South Korea's Kospi and Japan's Nikkei leading gains as investors returned to tech stocks. The rebound follows recent volatility, with markets now focused on corporate earnings and geopolitical risks.

Feb 3, 2026

Business

Fed's Rate Pause Sparks Internal Rift as Dissenter Warns of Faltering Labor Market

The Federal Reserve's decision to hold interest rates steady has exposed a deepening policy divide, with one governor publicly warning that inaction risks a significant deterioration in the jobs landscape.

Feb 3, 2026

Business

AbbVie's Q4 Earnings in Focus: Can the Pharma Giant Sustain Its Growth Momentum?

All eyes are on AbbVie as it prepares to release its fourth-quarter earnings. With a history of topping revenue forecasts, the market watches to see if its strategic shifts can continue to deliver amid evolving industry pressures.

Feb 3, 2026

Business

EnerSys Poised for Q4 Earnings Release: Key Metrics and Market Sentiment in Focus

Industrial battery giant EnerSys (ENS) is set to report its fiscal fourth-quarter results after Wednesday's market close. Investors are weighing strong recent performance against a history of revenue misses and a tempered growth outlook.

Feb 3, 2026

Business

Azenta Earnings on Deck: Can the Life Sciences Firm Beat Flat Revenue Forecasts?

Azenta, Inc. is set to report its quarterly earnings before the market opens Wednesday. Analysts project stagnant year-over-year revenue, placing the spotlight on the company's ability to navigate a challenging market for life sciences tools and services.

Feb 3, 2026

Business

STERIS Q4 Earnings Preview: Can the Medical Equipment Giant Sustain Its Momentum?

As Steris prepares to report its fiscal fourth-quarter results, investors are watching to see if the company can maintain its recent streak of topping revenue estimates against a backdrop of mixed signals from the broader healthcare equipment sector.

Feb 3, 2026